Page last updated: 2024-12-11

ah 1058

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

AH 1058: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9848860
SCHEMBL ID9455520
MeSH IDM0305448

Synonyms (12)

Synonym
SCHEMBL9455520
ah-1058
ah 1058
228123-15-7
piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-((2e)-3-(3-methoxy-2-nitrophenyl)-2-propenyl)-, monohydrochloride
z3xpw9jwmu ,
piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-((2e)-3-(3-methoxy-2-nitrophenyl)-2-propen-1-yl)-, hydrochloride (1:1)
unii-z3xpw9jwmu
Q27294961
ah-1058 hcl
1-[(e)-3-(3-methoxy-2-nitrophenyl)prop-2-enyl]-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
AKOS040745518
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's7 (77.78)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]